Advance Lifes. (521048)
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹41.99 |
| Market Cap | ₹26.14 Cr |
| P/E Ratio | 22.25 |
| ROCE | 4.43% |
| ROE | 2.51% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹20.05 — ₹41.99 |
| Sector | Textiles & Apparels |
| Book Value | ₹44.82 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹41.99, Advance Lifes. looks like the kind of cigar butt Graham might have examined. The market caps the company at just ₹26 Cr, while book value stands at ₹44.82 per share, so the stock trades at 0.94 times book. That appears to offer a margin of safety. But a low P/B only matters if the assets are real and can generate returns. Here, ROE is just 2.51% and ROCE is 4.43% – far below what I'd expect from a good business. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, and historical sales and profit growth are also 0.00%. This is not a growing franchise; it is a stagnant or barely operating entity. The P/E of 22.25 on such weak earnings is not cheap; it only reflects a very small earnings base. The Piotroski F-Score of 3/9 reinforces my concern about weak financial health. There is no dividend, no promoter holding data, and no debt-equity ratio disclosed, leaving too many unknowns. In the textile industry, with commodity products and no visible moat, low returns are common. So I would classify this as an asset play, not a great business. The share price is below stated book value, but the ultimate worth depends on whether those assets are truly valuable – or just stale inventory and old machinery. I would not buy on hope alone. I need evidence of operational improvement, clarity on liabilities, and honest capital allocation before trusting this apparent discount.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer